Glostrup University Hospital, Copenhagen
rigshospitalet.dkLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
106
Active
5
Phase 3
3
Total enrollment
105,290
Pipeline matrix
Showing 1 of 1 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Oral semaglutide | — | — | — | — | — | 1 |
Next readouts
- 2028-08
Top conditions
- Type 2 Diabetes5
- Rheumatoid Arthritis4
- Cardiovascular Disease4
- Healthy4
- Chronic Obstructive Pulmonary Disease3
- Epiretinal Membrane3
- Diabetic Retinopathy3
- Pain, Postoperative3
Frequently asked questions about Glostrup University Hospital, Copenhagen
- How many clinical trials does Glostrup University Hospital, Copenhagen have on ClinicalTrials.gov?
- Glostrup University Hospital, Copenhagen is listed as the lead sponsor on 106 clinical trials in ClinicalTrials.gov, 5 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Glostrup University Hospital, Copenhagen's trials are in Phase 3?
- 3 of Glostrup University Hospital, Copenhagen's trials are in Phase 3, spread across 1 active drug program.
- What therapeutic areas does Glostrup University Hospital, Copenhagen focus on?
- Glostrup University Hospital, Copenhagen's most-studied conditions on ClinicalTrials.gov are Type 2 Diabetes, Rheumatoid Arthritis, Cardiovascular Disease, Healthy, Chronic Obstructive Pulmonary Disease.
- When are Glostrup University Hospital, Copenhagen's next clinical trial readouts?
- Glostrup University Hospital, Copenhagen has 1 upcoming primary-completion readout tracked here; the soonest is “A Study Investigating Oral Semaglutide in People with Open-Angle Glaucoma”, expected around 2028-08.